Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients

Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of Multiple Sclerosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Multiple Sclerosis patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Multiple Sclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Sclerosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participant has a diagnosis of Multiple Sclerosis
Patient has self-identified as planning to enroll in an interventional clinical trial for Multiple Sclerosis
Patient is at least 18 years of age

Exclusion criteria

Inability to perform regular electronic reporting
Patient does not understand, sign, and return consent form
No diagnosis of Multiple Sclerosis confirmed

Treatment and study plan

Primary outcomes

Rate of patients who decide to enroll in a Multiple Sclerosis Clinical Trial

Time frame: 3 months
Number of patients who remain in Multiple Sclerosis clinical trial until completion

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

415-900-4227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Extensive Clinical Trial Experiences of Multiple Sclerosis Patients To Determine Trial Attributes Affecting Completion Rates For Specific Demographic Groups

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2026
First posted: Aug 16, 2022
Registry last updated: Jan 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed